What is Legionnaires' disease?

What is Legionnaires' Disease?

Legionnaires' disease is a severe form of pneumonia caused by inhalation of aerosolized water droplets contaminated with Legionella bacteria, primarily Legionella pneumophila, with mortality rates ranging from 10-40% depending on patient risk factors and disease severity. 1, 2, 3

Causative Organism and Transmission

• Legionnaires' disease is caused by aerobic gram-negative bacilli of the genus Legionella, with Legionella pneumophila being the most common pathogen 3
• Transmission occurs through inhalation of contaminated water aerosols from sources including cooling towers, showers, faucets, hot-water tanks, respiratory therapy equipment, and room-air humidifiers 1
• Person-to-person transmission has not been observed 1
• The incubation period is typically 2-10 days 1

Clinical Presentation and Severity

• The clinical spectrum ranges from asymptomatic infection to rapidly progressive pneumonia requiring intensive care 1
• Legionnaires' disease cannot be distinguished clinically or radiographically from other pneumonias, making laboratory confirmation essential 1
• Approximately one-third of cases require ICU admission, with 22.7% requiring mechanical ventilation and 1.5% requiring ECMO 2, 4
• The disease presents with severe lung injury, extrapulmonary symptoms (high fever, hyponatremia, CNS manifestations), and non-specific laboratory findings 5, 2

Mortality and Risk Factors

Mortality rates are substantial:

• Overall 30-day mortality: 11.9-25% 6, 2, 4
• Nosocomial cases: 40% mortality 1
• Community-acquired cases: 20% mortality 1

High-risk populations include:

• Severely immunosuppressed patients (hematopoietic stem cell or solid-organ transplant recipients) 1
• Patients with chronic underlying illnesses including hematologic malignancy, end-stage renal disease, cirrhosis, diabetes mellitus, chronic lung disease, or non-hematologic malignancy 1, 4
• Advanced age and immunocompromised status are independent predictors of mortality 1, 4
• Cirrhosis (OR 10.2) and lymphopenia at presentation (OR 2.09) are particularly strong predictors of 30-day mortality 4

Diagnostic Methods

Laboratory confirmation requires one of the following:

• Culture isolation of Legionella from respiratory secretions or tissues (most specific test) 1
• Urinary antigen testing for L. pneumophila serogroup 1 (detects 80-95% of community-acquired cases, sensitivity 70-90%, specificity nearly 99%) 7, 5, 8
• Microscopic visualization by immunofluorescent microscopy 1
• Four-fold rise in antibody titer to ≥1:128 in paired sera 1

Critical diagnostic caveats:

• Urinary antigen testing only detects L. pneumophila serogroup 1, missing other serogroups and species 7, 5
• Among PCR or culture-positive patients, urinary antigen was positive in only 25.6% 4
• No single laboratory test is 100% sensitive, so negative results do not exclude the diagnosis 1
• Testing is recommended for all patients with severe community-acquired pneumonia requiring ICU admission, immunocompromised hosts, and treatment failures 7, 5

Epidemiology

• Incidence has increased 9-fold in the United States from 2000 to 2018, with similar increases observed globally 6, 2, 8
• Legionnaires' disease accounts for approximately 5% of all community-acquired pneumonia but is one of the three most common causes requiring ICU admission 5, 2
• The disease remains significantly underreported despite improved diagnostic methods 8, 3